Dr Reddy’s Is Pushing For Progress On Multiple Fronts
CEO Sets Out How The Firm Is Remaining Competitive In Generics And Biosimilars
Whether in the competitive world of US generics, the growing global biosimilars arena, or promising new geographical markets, Dr Reddy’s is seeking to capitalize on its strengths to remain competitive while also pushing forward with ESG goals, CEO Erez Israeli tells Generics Bulletin.
